RAPAMYCIN HOLDINGS, INC. : Opens First Human Clinical Trial of its eRapaTM Compound Targeting Early Stage Prostate Cancer

  • Michael A Liss

Press/Media: Press / Media

PeriodSep 18 2018

Media coverage

2

Media coverage

  • TitleRAPAMYCIN HOLDINGS, INC. : Opens First Human Clinical Trial of its eRapaTM Compound Targeting Early Stage Prostate Cancer
    Media name/outletMarketScreener.com
    CountryUnited States
    Date9/18/18
    PersonsMichael A Liss
  • TitleRapamycin Holdings Inc. Opens First Human Clinical Trial of its eRapaTM Compound Targeting Early Stage Prostate Cancer
    Media name/outletBioPortfolio
    CountryUnited Kingdom
    Date9/18/18
    PersonsMichael A Liss